Metraipolis › archive › dc_96b42e1a69a8

Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring — Europe PMC PMID:35881550

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35881550
DOI
10.1289/ehp10009
License (as archived)
CC0-1.0
Archived
2026-10-17T10:50:35.846Z
SHA-256 of the archived text
d9ef69c7eaa5b24d2be467bfe3793e9ed5407ba982f958ed57cefb4927fb86a2
Stable URL of this page
https://metraipolis.com/documento/dc_96b42e1a69a8

How to cite

Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring — Europe PMC PMID:35881550 — Europe PMC (en), https://europepmc.org/article/MED/35881550 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_96b42e1a69a8 (Metraipolis archive dc_96b42e1a69a8, sha256 d9ef69c7eaa5b24d2be467bfe3793e9ed5407ba982f958ed57cefb4927fb86a2)
BibTeX
@misc{dc96b42e1a69a8,
  title = {Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring — Europe PMC PMID:35881550},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35881550},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_96b42e1a69a8; sha256 d9ef69c7eaa5b24d2be467bfe3793e9ed5407ba982f958ed57cefb4927fb86a2},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35881550. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: In human biomonitoring, blood is often used as a matrix to measure exposure to per- and polyfluoroalkyl substances (PFAS). Because the toxicokinetics of a substance (determining the steady-state blood concentration) may affect the toxic potency, the difference in toxicokinetics among PFAS has to be accounted for when blood concentrations are used in mixture risk assessment. Objectives: This research focuses on deriving relative potency factors (RPFs) at the blood serum level. These RPFs can be applied to PFAS concentrations in human blood, thereby facilitating mixture risk assessment with primary input from human biomonitoring studies. Methods: Toxicokinetic models are generated for 10 PFAS to estimate the internal exposure in the male rat at the blood serum level over time. By applying dose-response modeling, these internal exposures are used to derive quantitative internal RPFs based on liver effects. Results: Internal RPFs were successfully obtained for nine PFAS. Perfluorobutanoic acid (PFBA), perfluorohexanoic acid (PFHxA), perfluorononanoic acid (PFNA), perfluorododecanoic acid (PFDoDA), perfluorooctane sulfonic acid (PFOS), and hexafluoropropylene oxide-dimer acid (HFPO-DA, or GenX) were found to be more potent than perfluorooctanoic acid (PFOA) at the blood serum level in terms of relative liver weight increase, whereas perfluorobutane sulfonic acid (PFBS) and perfluorohexane sulfonic acid (PFHxS) were found to be less potent. The practical implementation of these internal RPFs is illustrated using the National Health and Nutrition Examination Survey (NHANES) biomonitoring data of 2017-2018. Discussion: It is recommended to assess the health risk resulting from exposure to PFAS as combined, aggregate exposure to the extent feasible. https://doi.org/10.1289/EHP10009.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2022 (prima pubblicazione 2022-07-26).
Identificativi: PMID 35881550 · PMCID PMC9320915 · DOI 10.1289/ehp10009.
Descrittori MeSH principali: Alkanesulfonic Acids; Fluorocarbons; Environmental Pollutants.
Pagina: https://europepmc.org/article/MED/35881550 — https://doi.org/10.1289/ehp10009. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-17T10:38:51.844Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.